Log In Sign Up

CVRx | Barostim

Barostimâ„¢ Baroreflex Activation Therapy is a new option for patients with heart failure that utilizes the carotid baroreflex to target autonomic imbalance in the cardiovascular system.

Barostim - Neuromodulation for Heart Failure
View all

open video

CVRx | Barostim

The Need for New Therapies to Address Chronic Heart Failure with Preserved Ejection Fraction (HFrEF) with Narrow QRS

open video

CVRx | Barostim

Baroreflex Activation Therapy (BAT): An Effective Therapy for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)

open video

CVRx | Barostim

Patient Identification, Implant Procedure and Patient Workflow for CVRx Barostim

open video

CVRx | Barostim

Considering Quality of Life as Part of Patient Selection for CVRx Barostim

open video

CVRx | Barostim

CVRx Barostim - Case Studies for Treatment of Chronic Heart Failure

open video

CVRx | Barostim

Expert consensus discussion of CVRx Barostim

Highlighted event

Barostim - Neuromodulation for Heart Failure


Join a renowned panel of Heart Failure and Electrophysiology experts to learn more about Barostim Baroreflex Activation Therapy (BAT), a new treatment option for HFrEF patients.

View Highlights
  • 12 Apr
  • 5:00 pm America/New_York
  • 1H

Videos
View all

open video

CVRx | Barostim

Autonomic Modulation as a Therapy for Heart Failure

open video

CVRx | Barostim

How to Select Patients who Could Benefit from Barostim

open video

CVRx | Barostim

Update on the Clinical Evidence Program for Barostim Therapy

open video

CVRx | Barostim

Consideration for using Barostim in Patients with Advanced Systolic Heart Failure